durect_logo.jpeg

DURECT is committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and lifesaving therapies based on its endogenous epigenetic regulator program.

Downloads

  • Twitter
  • LinkedIn
DurectRep.jpg

Contact

Gail Friedt, MSN, RN

Sr. Medical Science Liaison

DURECT Corporation

(650) 722-8176

gail.friedt@durect.com

www.durect.com

 

@DURECTCorp